Evaluation of tumor M2-pyruvate kinase (Tumor M2-PK) as a biomarker for pancreatic cancer

BACKGROUND: Expression of the dimeric M2 isoenzyme of pyruvate kinase, termed Tumor M2-PK, is increased in some human cancers. This study evaluates the potential role of pre-operative Tumor M2-PK as a marker of prognosis in patients with pancreatic malignancy. METHODS: Seventy-three consecutive pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandara, Indika A., Baltatzis, Minas, Sanyal, Sudip, Siriwardena, Ajith K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853155/
https://www.ncbi.nlm.nih.gov/pubmed/29540198
http://dx.doi.org/10.1186/s12957-018-1360-3